Vaxinano presents preclinical results of its anti-toxoplasma vaccine
Thursday, December 05th 2019
Didier Betbeder, CEO & CSO of Vaxinano, presents for the first time the preclinical results of the anti-toxoplasma vaccine, including non-human primates.